• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性 HCV 感染中 T 细胞耗竭的逆转。

Reversal of T Cell Exhaustion in Chronic HCV Infection.

机构信息

Department of Immunopathology of Infectious and Parasitic Diseases, Medical University of Warsaw, 02-091 Warsaw, Poland.

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, CH-8091 Zurich, Switzerland.

出版信息

Viruses. 2020 Jul 25;12(8):799. doi: 10.3390/v12080799.

DOI:10.3390/v12080799
PMID:32722372
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7472290/
Abstract

The long-term consequences of T cell responses' impairment in chronic HCV infection are not entirely characterized, although they may be essential in the context of the clinical course of infection, re-infection, treatment-mediated viral clearance and vaccine design. Furthermore, it is unclear whether a complete reinvigoration of HCV-specific T cell response may be feasible. In most studies, attempting to reverse the effects of compromised immune response quality by specific blockades of negative immune regulators, a restoration of functional competence of HCV-specific T cells was shown. This implies that HCV-induced immune dysfunction may be reversible. The advent of highly successful, direct-acting antiviral treatment (DAA) for chronic HCV infection instigated investigation whether the treatment-driven elimination of viral antigens restores T cell function. Most of studies demonstrated that DAA treatment may result in at least partial restoration of T cell immune function. They also suggest that a complete restoration comparable to that seen after spontaneous viral clearance may not be attained, pointing out that long-term antigenic stimulation imprints an irreversible change on the T cell compartment. Understanding the mechanisms of HCV-induced immune dysfunction and barriers to immune restoration following viral clearance is of utmost importance to diminish the possible long-term consequences of chronic HCV infection.

摘要

慢性 HCV 感染中 T 细胞反应受损的长期后果尚未完全明确,尽管它们在感染的临床过程、再感染、治疗介导的病毒清除和疫苗设计的背景下可能是至关重要的。此外,尚不清楚是否可以完全恢复 HCV 特异性 T 细胞反应。在大多数研究中,通过特异性阻断负性免疫调节剂来试图逆转免疫反应质量受损的影响,显示 HCV 特异性 T 细胞的功能能力得到恢复。这意味着 HCV 诱导的免疫功能障碍可能是可逆的。直接作用抗病毒治疗(DAA)对慢性 HCV 感染的高度成功应用促使人们研究治疗驱动的病毒抗原消除是否恢复 T 细胞功能。大多数研究表明,DAA 治疗可能导致 T 细胞免疫功能至少部分恢复。它们还表明,可能无法达到与自发病毒清除后观察到的完全恢复相当的程度,指出长期的抗原刺激对 T 细胞区室造成不可逆转的改变。了解 HCV 诱导的免疫功能障碍的机制以及清除病毒后免疫恢复的障碍对于减少慢性 HCV 感染的可能长期后果至关重要。

相似文献

1
Reversal of T Cell Exhaustion in Chronic HCV Infection.慢性 HCV 感染中 T 细胞耗竭的逆转。
Viruses. 2020 Jul 25;12(8):799. doi: 10.3390/v12080799.
2
Elimination of hepatitis C virus has limited impact on the functional and mitochondrial impairment of HCV-specific CD8+ T cell responses.清除丙型肝炎病毒对 HCV 特异性 CD8+ T 细胞反应的功能和线粒体损伤的影响有限。
J Hepatol. 2019 Nov;71(5):889-899. doi: 10.1016/j.jhep.2019.06.025. Epub 2019 Jul 8.
3
Partial restoration of immune response in Hepatitis C patients after viral clearance by direct-acting antiviral therapy.直接作用抗病毒治疗清除病毒后丙型肝炎患者免疫应答部分恢复。
PLoS One. 2021 Jul 9;16(7):e0254243. doi: 10.1371/journal.pone.0254243. eCollection 2021.
4
In Chronic Hepatitis C Infection, Myeloid-Derived Suppressor Cell Accumulation and T Cell Dysfunctions Revert Partially and Late After Successful Direct-Acting Antiviral Treatment.在慢性丙型肝炎感染中,髓源性抑制细胞的积累和 T 细胞功能障碍在成功的直接抗病毒治疗后部分和晚期恢复。
Front Cell Infect Microbiol. 2019 Jun 14;9:190. doi: 10.3389/fcimb.2019.00190. eCollection 2019.
5
Dynamic Changes in Ex Vivo T-Cell Function After Viral Clearance in Chronic HCV Infection.慢性 HCV 感染病毒清除后体外 T 细胞功能的动态变化。
J Infect Dis. 2019 Sep 13;220(8):1290-1301. doi: 10.1093/infdis/jiz291.
6
Restoration of HCV-Specific Immune Responses with Antiviral Therapy: A Case for DAA Treatment in Acute HCV Infection.抗病毒治疗恢复 HCV 特异性免疫应答:DAA 治疗急性 HCV 感染的理由。
Cells. 2019 Apr 5;8(4):317. doi: 10.3390/cells8040317.
7
Restoration of HCV-specific CD8+ T cell function by interferon-free therapy.无干扰素治疗恢复 HCV 特异性 CD8+ T 细胞功能。
J Hepatol. 2014 Sep;61(3):538-43. doi: 10.1016/j.jhep.2014.05.043. Epub 2014 Jun 4.
8
Peripheral PD-1 T Cells Co-expressing Inhibitory Receptors Predict SVR With Ultra Short Duration DAA Therapy in HCV Infection.外周血 PD-1 共表达抑制性受体预测 HCV 感染患者接受超短疗程 DAA 治疗后的 SVR。
Front Immunol. 2019 Jun 27;10:1470. doi: 10.3389/fimmu.2019.01470. eCollection 2019.
9
Lack of full CD8 functional restoration after antiviral treatment for acute and chronic hepatitis C virus infection.抗病毒治疗急性和慢性丙型肝炎病毒感染后缺乏完全的 CD8 功能恢复。
Gut. 2012 Jul;61(7):1076-84. doi: 10.1136/gutjnl-2011-300515. Epub 2012 Feb 15.
10
Direct-Acting Antiviral Treatment of HCV Infection Does Not Resolve the Dysfunction of Circulating CD8 T-Cells in Advanced Liver Disease.直接作用抗病毒药物治疗 HCV 感染并不能改善晚期肝病患者循环 CD8+T 细胞的功能障碍。
Front Immunol. 2019 Aug 13;10:1926. doi: 10.3389/fimmu.2019.01926. eCollection 2019.

引用本文的文献

1
Cure of chronic hepatitis C virus infection after DAA treatment only partially restores the functional capacity of exhausted T cell subsets: a systematic review.直接抗病毒药物治疗后慢性丙型肝炎病毒感染的治愈仅部分恢复耗竭性T细胞亚群的功能能力:一项系统评价
Front Immunol. 2025 Sep 1;16:1546915. doi: 10.3389/fimmu.2025.1546915. eCollection 2025.
2
Association between metabolic associated fatty liver disease and HCC risk after SVR in HCV patients: A systematic review and meta-analysis.丙型肝炎病毒(HCV)患者持续病毒学应答(SVR)后代谢相关脂肪性肝病与肝细胞癌(HCC)风险的关联:一项系统评价和荟萃分析
Clin Exp Hepatol. 2025 Jun;11(2):129-136. doi: 10.5114/ceh.2025.151896. Epub 2025 Jun 13.
3

本文引用的文献

1
Developmental Relationships of Four Exhausted CD8 T Cell Subsets Reveals Underlying Transcriptional and Epigenetic Landscape Control Mechanisms.四种耗竭 CD8 T 细胞亚群的发育关系揭示了潜在的转录和表观遗传调控机制。
Immunity. 2020 May 19;52(5):825-841.e8. doi: 10.1016/j.immuni.2020.04.014. Epub 2020 May 11.
2
Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma.功能失调的CD8 T细胞在人类黑色素瘤内形成一个增殖的、动态调节的区室。
Cell. 2020 Apr 30;181(3):747. doi: 10.1016/j.cell.2020.04.017.
3
Characterizing Hepatitis C Virus-Specific CD4 T Cells Following Viral-Vectored Vaccination, Directly Acting Antivirals, and Spontaneous Viral Cure.
Disease-Associated Shifts in Minor T Cell Subpopulations Define Distinct Immunopathology in HBV vs. HCV Infection.
疾病相关的次要T细胞亚群变化定义了HBV与HCV感染中不同的免疫病理学特征。
Int J Mol Sci. 2025 Aug 11;26(16):7761. doi: 10.3390/ijms26167761.
4
CD8 T Cell Hyperfunction and Reduced Tumour Control in Murine Models of Advanced Liver Disease.晚期肝病小鼠模型中CD8 T细胞功能亢进与肿瘤控制减弱
Eur J Immunol. 2025 Aug;55(8):e70026. doi: 10.1002/eji.70026.
5
Single cell immune profiling in ankylosing spondylitis reveals resistance of CD8 T cells to immune exhaustion.强直性脊柱炎的单细胞免疫分析揭示了CD8 T细胞对免疫耗竭的抗性。
iScience. 2025 Jun 6;28(7):112715. doi: 10.1016/j.isci.2025.112715. eCollection 2025 Jul 18.
6
Persistence of hepatitis C virus in peripheral blood mononuclear cells of patients who achieved sustained virological response following treatment with direct-acting antivirals is associated with a distinct pre-existing immune exhaustion status.在接受直接作用抗病毒药物治疗后实现持续病毒学应答的患者外周血单个核细胞中,丙型肝炎病毒的持续存在与一种独特的预先存在的免疫耗竭状态相关。
Sci Rep. 2025 Jun 6;15(1):19918. doi: 10.1038/s41598-025-05084-z.
7
Plasma levels of soluble PD-1, TIM-3, LAG-3 and galectin-3 and the degree of liver fibrosis in CHC and the impact of successful antiviral treatment on their levels.慢性丙型肝炎患者血浆中可溶性程序性死亡受体1(PD-1)、T细胞免疫球蛋白黏蛋白分子3(TIM-3)、淋巴细胞活化基因-3(LAG-3)和半乳糖凝集素-3水平以及肝纤维化程度,以及抗病毒治疗成功对其水平的影响。
Sci Rep. 2025 May 2;15(1):15436. doi: 10.1038/s41598-025-99096-4.
8
Immune checkpoint proteins are associated with persistently high liver stiffness after successful HCV treatment in people with HIV: a retrospective study.免疫检查点蛋白与HIV感染者成功治愈丙型肝炎病毒后持续高肝硬度相关:一项回顾性研究
Front Immunol. 2024 Dec 17;15:1505864. doi: 10.3389/fimmu.2024.1505864. eCollection 2024.
9
Immune Responses to Anti-Hepatitis C Virus Antibodies during Pre-Liver Transplantation Direct-Acting Antiviral Therapy in Hepatitis C Virus-Infected Recipients Associated with Post-Liver Transplantation Allograft Injury.丙型肝炎病毒感染受者肝移植前直接抗病毒治疗期间抗丙型肝炎病毒抗体的免疫反应与肝移植后同种异体移植物损伤的相关性
Antibodies (Basel). 2024 Jan 16;13(1):7. doi: 10.3390/antib13010007.
10
Immunological and senescence biomarker profiles in patients after spontaneous clearance of hepatitis C virus: gender implications for long-term health risk.丙型肝炎病毒自发清除后患者的免疫和衰老生物标志物谱:性别对长期健康风险的影响
Immun Ageing. 2023 Nov 17;20(1):62. doi: 10.1186/s12979-023-00387-z.
描述病毒载体疫苗接种、直接作用抗病毒药物和自发性病毒清除后丙型肝炎病毒特异性 CD4 T 细胞的特征。
Hepatology. 2020 Nov;72(5):1541-1555. doi: 10.1002/hep.31160.
4
Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection.《2019年丙型肝炎指南更新:美国肝病研究协会-美国传染病学会关于丙型肝炎病毒感染检测、管理及治疗的建议》
Hepatology. 2020 Feb;71(2):686-721. doi: 10.1002/hep.31060.
5
Proliferating Transitory T Cells with an Effector-like Transcriptional Signature Emerge from PD-1 Stem-like CD8 T Cells during Chronic Infection.在慢性感染期间,具有效应样转录特征的增殖暂态 T 细胞从 PD-1 干性 CD8 T 细胞中出现。
Immunity. 2019 Dec 17;51(6):1043-1058.e4. doi: 10.1016/j.immuni.2019.11.002. Epub 2019 Dec 3.
6
Follicular T helper cells shape the HCV-specific CD4+ T cell repertoire after virus elimination.滤泡辅助性 T 细胞在病毒清除后塑造 HCV 特异性 CD4+ T 细胞库。
J Clin Invest. 2020 Feb 3;130(2):998-1009. doi: 10.1172/JCI129642.
7
TCF-1-Centered Transcriptional Network Drives an Effector versus Exhausted CD8 T Cell-Fate Decision.TCF-1 为中心的转录网络驱动效应器与耗竭 CD8+T 细胞命运决定。
Immunity. 2019 Nov 19;51(5):840-855.e5. doi: 10.1016/j.immuni.2019.09.013. Epub 2019 Oct 9.
8
Regulatory T Cell Function Modulated After Successful Direct-Acting Antiviral Treatment for Chronic Hepatitis C Patients.慢性丙型肝炎患者经直接作用抗病毒治疗后调节性 T 细胞功能的变化。
Dig Dis Sci. 2020 May;65(5):1385-1395. doi: 10.1007/s10620-019-05850-w. Epub 2019 Sep 26.
9
Direct-Acting Antiviral Treatment of HCV Infection Does Not Resolve the Dysfunction of Circulating CD8 T-Cells in Advanced Liver Disease.直接作用抗病毒药物治疗 HCV 感染并不能改善晚期肝病患者循环 CD8+T 细胞的功能障碍。
Front Immunol. 2019 Aug 13;10:1926. doi: 10.3389/fimmu.2019.01926. eCollection 2019.
10
CD4 T cell exhaustion revealed by high PD-1 and LAG-3 expression and the loss of helper T cell function in chronic hepatitis B.慢性乙型肝炎中高表达 PD-1 和 LAG-3、辅助性 T 细胞功能丧失导致的 CD4 T 细胞耗竭。
BMC Immunol. 2019 Aug 7;20(1):27. doi: 10.1186/s12865-019-0309-9.